Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03595592
Title Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer (APTneo)
Acronym APTneo
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Fondazione Michelangelo
Age Groups: senior | adult
Covered Countries ITA | ESP | DEU | AUT

No variant requirements are available.